BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21524152)

  • 1. Development of multiple-unit colon-targeted drug delivery system by using alginate: in vitro and in vivo evaluation.
    Lai H; Zhu F; Yuan W; He N; Zhang Z; Zhang X; He Q
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1347-56. PubMed ID: 21524152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
    Sinha VR; Mittal BR; Kumria R
    Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
    Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
    J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
    Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
    Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.
    Lai H; Lin K; Zhang W; Zhang Z; Jie L; Wu Y; He Q
    Drug Dev Ind Pharm; 2010 Jan; 36(1):81-92. PubMed ID: 19640246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
    Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ
    Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of paeonol-beta-cyclodextrin inclusion complex loaded colon specific delivery tablets].
    Wang T; Cui Q; Cao Q; Cui J
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):2956-9. PubMed ID: 22308682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen.
    Veerareddy PR; Vemula SK
    J Drug Target; 2012 Sep; 20(8):703-14. PubMed ID: 22845842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting.
    Drechsler M; Garbacz G; Thomann R; Schubert R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):807-15. PubMed ID: 25301294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
    Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
    Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of alginate based mesalazine tablets for intestinal drug delivery.
    Tuğcu-Demiröz F; Acartürk F; Takka S; Konuş-Boyunağa O
    Eur J Pharm Biopharm; 2007 Sep; 67(2):491-7. PubMed ID: 17451926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of enzyme-controlled colonic drug delivery using amylose and hydroxypropyl methylcellulose: optimization by factorial design.
    Kshirsagar SJ; Bhalekar MR; Shewale NS; Godbole VP; Jagdale PK; Mohapatra SK
    Drug Deliv; 2011 Aug; 18(6):385-93. PubMed ID: 21449831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
    Patel MM; Shah TJ; Amin AF; Shah NN
    Pharm Dev Technol; 2009; 14(1):62-9. PubMed ID: 18802844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium.
    Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X
    Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.
    Maity S; Sa B
    AAPS PharmSciTech; 2016 Apr; 17(2):504-15. PubMed ID: 26271189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
    Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
    J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guar gum as potential film coating material for colon-specific delivery of fluorouracil.
    Ji CM; Xu HN; Wu W
    J Biomater Appl; 2009 Jan; 23(4):311-29. PubMed ID: 18667456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.